ANAVEX 1-41

N/A

Report date: 2023/02/01 18:00:10
NME

Base Information

Drug NameANAVEX 1-41
Drug Alias NameANAVEX 1-41
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChloride channel modulatorsSigma opioid receptor agonistsSodium channels modulators +[4] 
TargetsChloride channelSigma opioid receptorSodium channels +[4] 
Therapy Area/IndicationsDepressionNeurodegenerative DiseasesStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnavex Life Sciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesAnavex Life Sciences Corp
Inactive CompaniesN/A
Active IndicationsDepressionNeurodegenerative DiseasesStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A